Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001144204-18-033938)

Filing Details

Accession Number:: 0001144204-18-033938
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2018-06-12 17:31:15
Reporting Period:: 2018-06-01

Accepted Time:: 2018-06-12 17:31:15
Original Submission Date:: 2018-06-11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1644963	Avenue Therapeutics Inc.	ATXI	()	4/A

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
941841	Md A Lindsay Rosenwald	C/O Avenue Therapeutics, Inc. 2 Gansevoort Street, 9Th Floor New York NY 10014		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-06-01	8,666	$4.15	28,666	No	4	P	Direct
Common Stock	Acquisiton	2018-06-04	3,800	$4.19	32,466	No	4	P	Direct
Common Stock	Acquisiton	2018-06-05	8,400	$4.28	40,866	No	4	P	Direct
Common Stock	Acquisiton	2018-06-06	9,100	$4.35	49,966	No	4	P	Direct
Common Stock	Acquisiton	2018-06-07	14,800	$4.32	64,766	No	4	P	Direct
Common Stock	Acquisiton	2018-06-08	5,234	$4.34	70,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

Includes 10,000 shares of restricted stock.